ATE228122T1 - Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen - Google Patents

Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen

Info

Publication number
ATE228122T1
ATE228122T1 AT00905758T AT00905758T ATE228122T1 AT E228122 T1 ATE228122 T1 AT E228122T1 AT 00905758 T AT00905758 T AT 00905758T AT 00905758 T AT00905758 T AT 00905758T AT E228122 T1 ATE228122 T1 AT E228122T1
Authority
AT
Austria
Prior art keywords
hydroxamat
inhibitors
reverse
matrix metalloproteinases
metalloproteinases
Prior art date
Application number
AT00905758T
Other languages
English (en)
Inventor
Michael L Curtin
Yujia Dai
Steven K Davidsen
Howard R Heyman
James H Holmes
Michael R Michaelides
Douglas H Steinman
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE228122T1 publication Critical patent/ATE228122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00905758T 1999-01-27 2000-01-27 Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen ATE228122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23908799A 1999-01-27 1999-01-27
PCT/US2000/002038 WO2000044739A1 (en) 1999-01-27 2000-01-27 Reverse hydroxamate inhibitors of matrix metalloproteinases

Publications (1)

Publication Number Publication Date
ATE228122T1 true ATE228122T1 (de) 2002-12-15

Family

ID=22900549

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905758T ATE228122T1 (de) 1999-01-27 2000-01-27 Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen

Country Status (28)

Country Link
US (1) US20020007060A1 (de)
EP (1) EP1147101B1 (de)
JP (1) JP4718686B2 (de)
KR (1) KR100748010B1 (de)
CN (1) CN1222519C (de)
AR (1) AR029329A1 (de)
AT (1) ATE228122T1 (de)
AU (1) AU764383B2 (de)
BG (1) BG105782A (de)
BR (1) BR0007278A (de)
CA (1) CA2358951C (de)
CO (1) CO5150194A1 (de)
CZ (1) CZ20012591A3 (de)
DE (1) DE60000819T2 (de)
DK (1) DK1147101T3 (de)
ES (1) ES2187443T3 (de)
HK (1) HK1043115A1 (de)
HU (1) HUP0105477A2 (de)
IL (1) IL143713A0 (de)
NO (1) NO20013669L (de)
NZ (1) NZ512372A (de)
PL (1) PL349771A1 (de)
PT (1) PT1147101E (de)
SK (1) SK10582001A3 (de)
TR (1) TR200102159T2 (de)
TW (1) TWI225486B (de)
WO (1) WO2000044739A1 (de)
ZA (1) ZA200104979B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
WO2003063762A2 (en) * 2001-01-12 2003-08-07 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
ATE420068T1 (de) 2001-09-07 2009-01-15 Kaken Pharma Co Ltd Reverse hydroxamsäurederivate
EP2298733B1 (de) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilinderivate mit einer Hydroxyamino- oder Acyloxyaminocycloalkylgruppe
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
WO2015107139A1 (en) 2014-01-17 2015-07-23 Proyecto De Biomedicina Cima, S.L. Compounds for use as antifibrinolytic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE225343T1 (de) * 1995-12-20 2002-10-15 Hoffmann La Roche Matrix-metalloprotease inhibitoren

Also Published As

Publication number Publication date
NO20013669L (no) 2001-09-27
IL143713A0 (en) 2002-04-21
CA2358951A1 (en) 2000-08-03
SK10582001A3 (sk) 2001-12-03
CA2358951C (en) 2009-10-20
CN1339032A (zh) 2002-03-06
ES2187443T3 (es) 2003-06-16
TWI225486B (en) 2004-12-21
ZA200104979B (en) 2002-09-18
PT1147101E (pt) 2003-04-30
TR200102159T2 (tr) 2001-12-21
US20020007060A1 (en) 2002-01-17
CZ20012591A3 (cs) 2001-12-12
KR100748010B1 (ko) 2007-08-09
EP1147101B1 (de) 2002-11-20
JP4718686B2 (ja) 2011-07-06
BR0007278A (pt) 2001-11-27
CN1222519C (zh) 2005-10-12
AR029329A1 (es) 2003-06-25
WO2000044739A1 (en) 2000-08-03
HUP0105477A2 (hu) 2002-05-29
PL349771A1 (en) 2002-09-09
AU2739100A (en) 2000-08-18
KR20010101709A (ko) 2001-11-14
NZ512372A (en) 2003-01-31
CO5150194A1 (es) 2002-04-29
BG105782A (en) 2002-04-30
DE60000819D1 (de) 2003-01-02
DE60000819T2 (de) 2003-09-04
NO20013669D0 (no) 2001-07-26
EP1147101A1 (de) 2001-10-24
HK1043115A1 (zh) 2002-09-06
JP2002535398A (ja) 2002-10-22
DK1147101T3 (da) 2003-03-10
AU764383B2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
DE60002193D1 (de) Metalloprotease inhibitoren
NO995433D0 (no) Protease-inhibitorer
NO20034042L (no) Metallproteinase-inhibitorer
NO20012980D0 (no) Proteaseinhibitorer
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
NO991922D0 (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
ATE524441T1 (de) Vla-4-inhibitoren
ATE257151T1 (de) Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
NO20034032L (no) Metallproteinase-inhibitorer
NO996313L (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
NO995434D0 (no) Proteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
NO20014243L (no) Dihetero-substituerte metalloproteaseinhibitorer
NO995268D0 (no) Proteaseinhibitorer
EE200100611A (et) NOS inhibiitorite uued farmatseutilised kombinatsioonid
DK1047665T3 (da) Matrix metalloprotease inhibitorer
DE50115086D1 (de) Lösungen von UV-vernetzbaren Polyacrylaten
DE60024101D1 (de) Enzyminhibitoren
ATE228122T1 (de) Umgekehrt hydroxamat inhibitoren von matrix metalloproteinasen
DE60031450D1 (de) Polymorph v von torasemid
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
DE60124397D1 (de) Inhibitoren von serinproteasen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1147101

Country of ref document: EP

REN Ceased due to non-payment of the annual fee